Markus Hoffmann
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Head and Neck Cancer Studies 52
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Tibor Görögh (26 shared papers)Silke Tribius (12 shared papers)Stefan Gottschlich (18 shared papers)Tomas Kahn (8 shared papers)Petra Ambrosch (17 shared papers)Elgar Susanne Quabius (23 shared papers)Elisabeth Schwarz (4 shared papers)Steffen Maune (14 shared papers)
- Journals
- Cancer Letters (5 papers)International Journal of Cancer (5 papers)Translational Oncology (3 papers)Oral Oncology (3 papers)European Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Markus Hoffmann
62 papers receiving 1.4k citations
Markus Hoffmann's Hit Papers
Peers
Comparison fields: 5 of 63
- Otorhinolaryngology 965
- Cancer Research 100
- Epidemiology 166
- Oncology 95
- Periodontics 20
Countries citing papers authored by Markus Hoffmann
This map shows the geographic impact of Markus Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hoffmann more than expected).
Fields of papers citing papers by Markus Hoffmann
This network shows the impact of papers produced by Markus Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hoffmann. The network helps show where Markus Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis Hit paper breakdown → | 2023 | 202 |
| 2 | 2010 | 116 | |
| 3 | 2005 | 80 | |
| 4 | 2012 | 77 | |
| 5 | 2012 | 75 | |
| 6 | 2000 | 72 | |
| 7 | 2005 | 46 | |
| 8 | 2013 | 40 | |
| 9 | 2007 | 39 | |
| 10 | 2014 | 39 | |
| 11 | 1993 | 37 | |
| 12 | 2011 | 36 | |
| 13 | 2005 | 30 | |
| 14 | 2013 | 30 | |
| 15 | Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas. | 2003 | 29 |
| 16 | 2008 | 29 | |
| 17 | 2013 | 28 | |
| 18 | 2017 | 28 | |
| 19 | 2004 | 24 | |
| 20 | 2014 | 24 |
About Markus Hoffmann
Markus Hoffmann is a scholar working on Otorhinolaryngology, Cancer Research, Epidemiology, Oncology and Immunology, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (52 papers), Cervical Cancer and HPV Research (5 papers), Cancer-related Molecular Pathways (3 papers), Head and Neck Anomalies (3 papers), Protease and Inhibitor Mechanisms (2 papers), Tracheal and airway disorders (2 papers), Palliative and Oncologic Care (2 papers) and Palliative Care and End-of-Life Issues (2 papers). The work is most often cited by research in Otorhinolaryngology (965 citations), Cancer Research (100 citations), Epidemiology (166 citations), Oncology (95 citations) and Periodontics (20 citations). Markus Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Tibor Görögh, Silke Tribius, Stefan Gottschlich, Tomas Kahn, Petra Ambrosch, Elgar Susanne Quabius, Elisabeth Schwarz, Steffen Maune, Heinrich H. Rudert and Werner Rittgen. Their work appears in journals such as Cancer Letters, International Journal of Cancer, Translational Oncology, Oral Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.